Fundraising Fox

Anthera Pharmaceuticals

Hayward, US · Delaware corporation · 2 known investors

Developing products for diseases associated with inflammation. (NASDAQ: ANTH)

Biotech

Founders & leadership

ML
May LiuExecutive

Investors · 2

Pappas CapitalDurham
Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 1 round · 2017

▶$15MraisedJan 2018 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • May LiuExecutive Officer
Offering amount
$15M
Amount sold
$15M
Sales commissions
$1.1M
Placement agents
Piper Jaffray & Co.
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Anthera shares plunge as company drops failed CF drug | BioPharma Divebiopharmadive.com · Mar 2018Anthera Pharmaceuticals announces pricing of $31.5 million PIPE financing - Pappas Capitalpappas-capital.com · Sep 2010Anthera Pharmaceuticals, Inc. Secures $36 Million Venture Financing To Initiate Clinical Programs - BioSpacebiospace.com · Sep 2006Anthera raises $36M for clinical development work | Fierce Biotechfiercebiotech.com · Sep 2006Anthera Pharmaceuticals, Inc. Appoints David E. Thompson To Board Of Directors - BioSpacebiospace.com · Nov 2005

Frequently asked questions

What does Anthera Pharmaceuticals do?
Developing products for diseases associated with inflammation. (NASDAQ: ANTH)
Who are Anthera Pharmaceuticals's investors?
Anthera Pharmaceuticals's investors include Pappas Capital, Sofinnova Ventures.
How much funding has Anthera Pharmaceuticals raised?
Anthera Pharmaceuticals has disclosed $15M raised across 1 round.
Where is Anthera Pharmaceuticals headquartered?
Anthera Pharmaceuticals is headquartered in Hayward, US.